| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0166-6851(93)90158-T |
| P698 | PubMed publication ID | 8259133 |
| P2093 | author name string | Konings RN | |
| Kaslow DC | |||
| Jansen J | |||
| Schoenmakers JG | |||
| Beckers PJ | |||
| Kocken CH | |||
| Ponnudurai T | |||
| Kaan AM | |||
| P433 | issue | 1 | |
| P921 | main subject | Plasmodium falciparum | Q311383 |
| 6-cysteine protein | Q56589036 | ||
| 6-cysteine protein | Q56739219 | ||
| P304 | page(s) | 59-68 | |
| P577 | publication date | 1993-09-01 | |
| P1433 | published in | Molecular and Biochemical Parasitology | Q15752756 |
| P1476 | title | Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparum | |
| P478 | volume | 61 |
| Q92669430 | A C-terminal Pfs48/45 malaria transmission-blocking vaccine candidate produced in the baculovirus expression system |
| Q91723010 | A Plant-Produced in vivo deglycosylated full-length Pfs48/45 as a Transmission-Blocking Vaccine Candidate against malaria |
| Q39467691 | A Plasmodium falciparum 48/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodies |
| Q30043154 | A central role for P48/45 in malaria parasite male gamete fertility |
| Q39520295 | A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages |
| Q90732916 | An MFS-Domain Protein Pb115 Plays a Critical Role in Gamete Fertilization of the Malaria Parasite Plasmodium berghei |
| Q47915916 | Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry |
| Q92965786 | Antibodies against Plasmodium falciparum malaria at the molecular level |
| Q44146892 | Antibodies to Plasmodium vivax transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 do not show synergism |
| Q34005142 | Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes |
| Q38168906 | Application of wheat germ cell-free protein expression system for novel malaria vaccine candidate discovery |
| Q47857505 | Assembly and expression of a synthetic gene encoding the antigen Pfs48/45 of the human malaria parasite Plasmodium falciparum in yeast |
| Q56358374 | Characterization of Plasmodium berghei Pbg37 as Both a Pre- and Postfertilization Antigen with Transmission-Blocking Potential |
| Q35718341 | Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum |
| Q34460332 | Comparative genomics in Plasmodium: a tool for the identification of genes and functional analysis. |
| Q33750638 | Construct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine |
| Q33521214 | Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparum |
| Q36670217 | Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice |
| Q34543547 | Dressed for success: the surface coats of insect-borne protozoan parasites |
| Q34177472 | Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination |
| Q47829675 | Epitope analysis of the malaria surface antigen pfs48/45 identifies a subdomain that elicits transmission blocking antibodies. |
| Q40159945 | Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite |
| Q49615371 | FRG3, a Target of slmiR482e-3p, Provides Resistance against the Fungal Pathogen Fusarium oxysporum in Tomato |
| Q58765365 | Functional Conservation of P48/45 Proteins in the Transmission Stages of (Human Malaria Parasite) and . (Murine Malaria Parasite) |
| Q34999437 | Functional characterisation of sexual stage specific proteins in Plasmodium falciparum |
| Q43933339 | Genetic complexity and gametocyte production of Plasmodium falciparum in Fulani and Mossi communities in Burkina Faso |
| Q34604206 | Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum |
| Q43645737 | Heterologous expression of the C-terminal antigenic domain of the malaria vaccine candidate Pfs48/45 in the green algae Chlamydomonas reinhardtii |
| Q47850151 | Identification of additional members define a Plasmodium falciparum gene superfamily which includes Pfs48/45 and Pfs230. |
| Q92001627 | Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites |
| Q34000822 | Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodies |
| Q47837358 | Immunological properties of recombinant proteins of the transmission blocking vaccine candidate, Pfs48/45, of the human malaria parasite Plasmodium falciparum produced in Escherichia coli. |
| Q34492582 | Infection with Plasmodium berghei boosts antibody responses primed by a DNA vaccine encoding gametocyte antigen Pbs48/45. |
| Q36795388 | Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America. |
| Q44169388 | Malaria transmission-blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production |
| Q96607419 | Malaria vaccines since 2000: progress, priorities, products |
| Q34352458 | MicroRNAs suppress NB domain genes in tomato that confer resistance to Fusarium oxysporum |
| Q30662214 | Mitochondrial ATP synthase is dispensable in blood-stage Plasmodium berghei rodent malaria but essential in the mosquito phase |
| Q35138720 | N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity |
| Q35212991 | Orthology between the genomes of Plasmodium falciparum and rodent malaria parasites: possible practical applications. |
| Q28216287 | PSLAP, a protein with multiple adhesive motifs, is expressed in Plasmodium falciparum gametocytes |
| Q64898220 | Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum. |
| Q35548285 | Pfs230: from malaria transmission-blocking vaccine candidate toward function |
| Q39504399 | Plasmodium vivax gametocyte proteins, Pvs48/45 and Pvs47, induce transmission-reducing antibodies by DNA immunization |
| Q48326910 | Polymorphism in the gene encoding the Pfs48/45 antigen of Plasmodium falciparum. XI. Asembo Bay Cohort Project |
| Q48007592 | Production of non-glycosylated recombinant proteins in Nicotiana benthamiana plants by co-expressing bacterial PNGase F. |
| Q40701948 | Proteins on the surface of the malaria parasite and cell invasion |
| Q36394182 | Recent advances in recombinant protein-based malaria vaccines |
| Q44068863 | Serum antibodies induced by intranasal immunization of mice with Plasmodium vivax Pvs25 co-administered with cholera toxin completely block parasite transmission to mosquitoes |
| Q30832639 | Shotgun DNA microarrays and stage-specific gene expression in Plasmodium falciparum malaria |
| Q36998403 | Single-dose microparticle delivery of a malaria transmission-blocking vaccine elicits a long-lasting functional antibody response. |
| Q30390705 | Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230. |
| Q58115505 | Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45 |
| Q44029884 | Targeting and sequestration of truncated Pfs230 in an intraerythrocytic compartment during Plasmodium falciparum gametocytogenesis |
| Q41658117 | The importance of transmission-blocking immunity in the control of infections by apicomplexan parasites |
| Q38789240 | The s48/45 six-cysteine proteins: mediators of interaction throughout the Plasmodium life cycle |
| Q33553363 | Three members of the 6-cys protein family of Plasmodium play a role in gamete fertility |
| Q38775588 | Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine |
| Q36364246 | Transmission blocking immunity in Plasmodium vivax malaria: antibodies raised against a peptide block parasite development in the mosquito vector |
| Q44145217 | Transmission blocking malaria vaccines |
| Q40979878 | Transmission blocking malaria vaccines: Assays and candidates in clinical development |
| Q92954169 | Transmission-Blocking Vaccines: Old Friends and New Prospects |
| Q36267184 | Transmission-blocking activity of antibodies to Plasmodium falciparum GLURP.10C chimeric protein formulated in different adjuvants |
| Q44168384 | Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing |
| Q28078982 | Transmission-blocking strategies: the roadmap from laboratory bench to the community |
| Q35051320 | Transmission-blocking vaccine of vivax malaria |
| Q39122635 | Transmission-blocking vaccines: uses and current status of development |
| Q35088997 | Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax |
Search more.